HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ex vivo sputum analysis reveals impairment of protease-dependent mucus degradation by plasma proteins in acute asthma.

AbstractRATIONALE:
Airway mucus plugs, composed of mucin glycoproteins mixed with plasma proteins, are an important cause of airway obstruction in acute severe asthma, and they are poorly treated with current therapies.
OBJECTIVES:
To investigate mechanisms of airway mucus clearance in health and in acute severe asthma.
METHODS:
We collected airway mucus from patients with asthma and nonasthmatic control subjects, using sputum induction or tracheal aspiration. We used rheological methods complemented by centrifugation-based mucin size profiling and immunoblotting to characterize the physical properties of the mucus gel, the size profiles of mucins, and the degradation products of albumin in airway mucus.
MEASUREMENTS AND MAIN RESULTS:
Repeated ex vivo measures of size and entanglement of mucin polymers in airway mucus from nonasthmatic control subjects showed that the mucus gel is normally degraded by proteases and that albumin inhibits this degradation. In airway mucus collected from patients with asthma at various time points during acute asthma exacerbation, protease-driven mucus degradation was inhibited at the height of exacerbation but was restored during recovery. In immunoblots of human serum albumin digested by neutrophil elastase and in immunoblots of airway mucus, we found that albumin was a substrate of neutrophil elastase and that products of albumin degradation were abundant in airway mucus during acute asthma exacerbation.
CONCLUSIONS:
Rheological methods complemented by centrifugation-based mucin size profiling of airway mucins in health and acute asthma reveal that mucin degradation is inhibited in acute asthma, and that an excess of plasma proteins present in acute asthma inhibits the degradation of mucins in a protease-dependent manner. These findings identify a novel mechanism whereby plasma exudation may impair airway mucus clearance.
AuthorsAnh L Innes, Stephen D Carrington, David J Thornton, Sara Kirkham, Karine Rousseau, Ryan H Dougherty, Wilfred W Raymond, George H Caughey, Susan J Muller, John V Fahy
JournalAmerican journal of respiratory and critical care medicine (Am J Respir Crit Care Med) Vol. 180 Issue 3 Pg. 203-10 (Aug 01 2009) ISSN: 1535-4970 [Electronic] United States
PMID19423716 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Mucins
  • Secretory Leukocyte Peptidase Inhibitor
  • Serine Proteinase Inhibitors
Topics
  • Acute Disease
  • Adult
  • Aged
  • Asthma (drug therapy, metabolism)
  • Elasticity
  • Electrophoresis, Gel, Two-Dimensional
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoblotting
  • Male
  • Middle Aged
  • Molecular Weight
  • Mucins (analysis)
  • Mucociliary Clearance (drug effects)
  • Secretory Leukocyte Peptidase Inhibitor (pharmacology)
  • Serine Proteinase Inhibitors (pharmacology)
  • Sputum (chemistry, drug effects)
  • Viscosity
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: